Craniopharyngioma in Children: Long-term Outcomes.
The survival rate for childhood craniopharyngioma has been improving, with more long-term survivors. Unfortunately it is rare for the patient to be normal, either from the disease itself or from the effects of treatment. Long-term survivors of childhood craniopharyngioma suffer a number of impairments, which include visual loss, endocrinopathy, hypothalamic dysfunction, cerebrovascular problems, neurologic and neurocognitive dysfunction. Pituitary insufficiency is present in almost 100%. Visual and hypothalamic dysfunction is common. There is a high risk of metabolic syndrome and increased risk of cerebrovascular disease, including stroke and Moyamoya syndrome. Cognitive, psychosocial, and emotional problems are prevalent. Finally, there is a higher risk of premature death among survivors of craniopharyngioma, and often this is not from tumor recurrence. It is important to consider craniopharyngioma as a chronic disease. There is no perfect treatment. The treatment has to be tailored to the individual patient to minimize dysfunction caused by tumor and treatments. So "cure" of the tumor does not mean a normal patient. The management of the patient and family needs multidisciplinary evaluation and should involve ophthalmology, endocrinology, neurosurgery, oncology, and psychology. Furthermore, it is also important to address emotional issues and social integration.
Division of Neurosurgery, Department of Surgery, BC Children's Hospital and University of British Columbia.
Paul
P
Steinbok
D002318:Cardiovascular Diseases / Q000209:etiology; D002648:Child; D003397:Craniopharyngioma / Q000628:therapy; D004700:Endocrine System Diseases / Q000209:etiology; D006801:Humans; D010911:Pituitary Neoplasms / Q000628:therapy; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome